Vaso Corporation announced the divestiture of its subsidiary, VasoHealthcare IT Corp, to Nano-X Imaging Ltd.
The decision aims to sharpen focus on core operations and competencies, providing a positive outlook for shareholders.
The transaction consideration is up to $800,000, with an earnout based on post-closing performance.
Strategic Divestiture
The sale of VasoHealthcare IT Corp is part of a strategic move to enhance core business focus.
Transaction Consideration
The divestiture involves a transaction consideration of up to $800,000, with an earnout component based on future performance.
Focus on Core Operations
Vaso aims to reinvest proceeds to strengthen other business lines and strategic initiatives post the divestiture.
- The divestiture will allow Vaso to concentrate on its primary operations and key competencies.
- Vaso expects the sale to have a positive impact on shareholders and provide a promising future for the VasoHealthcare IT team as part of Nanox.
The divestiture of VasoHealthcare IT Corp reflects a strategic decision to enhance Vaso Corporation's operational focus and leverage opportunities for further growth and development in its core businesses.